Much Ado About Nothing

As an investor whom, I guess, has made two mistakes so far, I am not panicked in any way about my mission, although I feel I have wasted some time being patient. Today, the other stock I hold in my portfolio, a company called Cleveland BioLabs Inc.(CBLI) announced third quarter earnings today. Like many biopharmaceutical companies, stock price has nothing at all to do with earnings as it does with prospective news. CBLI posted a lesser net loss than a year ago but less revenues also. This company has never been profitable since its inception,so why would anyone invest in CBLI? Let me give you my theory. Some institutions hold substantial amounts of stock in this company. These institutions make a living trading securities. Institutions trading CBLI have not covered their short positions in this company for the simple fact that there is no volume changing hands at current price levels. Today's volume was a little higher than the median volume traded in CBLI but nothing to get excited about after its earnings announcement today. Until I see excessive volume at these price levels will I begin to get enthused. My feeling is that based on what the information given in  today;s earnings report,there is a positive hint of potential growth. A Phase 1 study of Entolimod, the drug that CBLI is putting its hopes,will be completed in the first half of 2015. My hope is that the price of CBLI will at least double by the first half of next year based on the potential success of these trials.
Investing in CBLI is not for the feint of heart but neither is investing in general. To be successful investor,one has to think like the institutions who hold the inventory of stocks in the companyone is invested..and even then you are guessing human nature.